While factors associating with personal stigma regarding how one would view and treat others have been identified, the discrepancies between perceived and personal stigma have received less research attention.
LH devised the basic computational approaches, carried out the initial data analysis, identified the discrepancies discussed and drafted an initial report.
Had we assembled all the relevant information we now know to have been available in Australia before the PBS listing of rofecoxib, we could have identified the discrepancies between the profile of the OA/RA patients included in the analysed rofecoxib RCTs and the profile of the local OA/RA patient groups aged 65 years and over.
In this paper, we identify the discrepancy of the hydrographers' rating curves used to derive the historical discharge data series and proposed a modification by bias correction which is also in the form of power function as the traditional rating curve.
This study was performed in two periods, 1/an audit to identify the discrepancies of the medical prescriptions, 2/a "before/after" intervention study to evaluate the impact on medical prescriptions.
Improving our understanding of the dynamic balance between pro- and anti-inflammatory responses and identifying the discrepancies between preclinical studies and clinical trials may lead to the design of more effective therapies.
Using United Kingdom data from 2010, we compared research funding from the National Cancer Research Institute to this YLL burden metric for 26 types of cancers in order to identify the discrepancies between cancer research funding allocation and societal burden.
As before, the effect of the SPI was identified as the discrepancy between the two arms of the study in the change experienced from the periods before and after the intervention.
Furthermore, diagnoses made in the primary care setting by patients' general practitioners were not included in our data, and our estimates of comorbidity prevalence are likely to be underestimates, as can be identified by the discrepancy between diseases and marker drugs.
We have not yet identified the molecular pathway explaining the discrepancy observed.
Identifying the specific discrepancies between EBPs and community care practices have been described as the most potent targets for quality improvement efforts (Garland et al. 2010).
